This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $1,650.00 fixed-price with economic price adjustment delivery order is for the Arthrex ACP Double Syringe System, a specialized medical device used for orthopedic procedures. The contract has an ultimate completion date of December 27, 2024. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has been awarded this contract without any set-aside designation, indicating its strong competitive position in the federal market. The company also holds a larger $471,048,172.66 Indefinite Delivery Contract (IDC) with the DLA, which allows VA medical centers nationwide to acquire Arthrex's innovative orthopedic technologies through task orders. This demonstrates Arthrex's ability to efficiently support government healthcare systems with specialized orthopedic solutions for veterans and military personnel.
Generated 3/24/25, 9:44 AM